Frances Xu

Herbert Smith Freehills (China)
Lawyer (Partner)

Frances is a Partner at the Joint Operation firm Kewei in Shanghai. She advises on competition law issues across a broad range of industries, including pharmaceuticals, TMT, automotive, luxury products, energy, essential facilities and public utilities.

Linked authors

Herbert Smith Freehills (Hong Kong)
Herbert Smith Freehills (Hong Kong)

Articles

17 Bulletin

Frances Xu, Adelaide Luke, Frederick Good The Chinese State Administration for Market Regulation fines three pharmaceutical companies for abuse of dominance in the distribution of injectable drug and confirms that medical devices sectors continue to be an enforcement priority amid the COVID-19 outbreak (Kanghui / Puyunhui / Taiyangshen)

17

On 9 April 2020, China’s State Administration for Market Regulation (SAMR) fined 3 pharmaceutical companies for abuse of dominance in the distribution of injectable calcium gluconate Active Pharmaceutical Ingredient (API). The three companies were found to be in breach of the PRC’s Anti-Monopoly (...)

Send a message